3DBio Therapeutics

Stronghold provides a wide range of services including product development, manufacturing, and direct distribution. Stronghold “Protection For All” products are engineered and built with the highest quality materials to meet the needs of first responders, essential workers, and you.

BrainStorm Cell Therapeutics is a leading biotechnology company based in New York City, specializing in the development of innovative autologous cellular therapies for highly debilitating neurodegenerative diseases. Their groundbreaking NurOwn technology platform aims to redefine the field of autologous cellular therapeutics, providing new treatment options for patients suffering from conditions with limited remedies. With a focus on unmet medical needs, BrainStorm is dedicated to defeating neurodegenerative diseases through their clinical-stage research and development. Their autologous MSC-NTF cell therapy has received Fast Track designation from the U.S. FDA for amyotrophic lateral sclerosis (ALS) and has completed a phase 3 pivotal trial in the United States. Additionally, BrainStorm has conducted a phase 2 study for progressive multiple sclerosis (MS), further demonstrating their commitment to improving the lives of patients affected by these conditions.Generated from the website

Fibrocell Science is a leading cell and gene therapy company based in New York, NY, dedicated to developing innovative treatments for genetic diseases. With a focus on autologous fibroblast technology and gene therapy, they aim to provide relief to patients and families affected by devastating conditions such as Dystrophic Epidermolysis Bullosa (DEB). Castle Creek Biosciences, Inc., located in Exton, PA, is committed to helping patients in need through their gene therapy for Dystrophic Epidermolysis Bullosa (DEB). As a leading biotech company, they are focused on developing novel treatments to improve the lives of individuals and families affected by this genetic disease.Generated from the website